Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short-term Investments (2017 - 2025)

Dr Reddys Laboratories (RDY) has 8 years of Short-term Investments data on record, last reported at $2.0 million in Q1 2024.

  • For Q1 2024, Short-term Investments fell 86.42% year-over-year to $2.0 million; the TTM value through Mar 2024 reached $2.0 million, down 86.42%, while the annual FY2025 figure was $506.0 million, 24685.25% up from the prior year.
  • Short-term Investments reached $2.0 million in Q1 2024 per RDY's latest filing, down from $15.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $270.8 million in Q1 2021 and bottomed at $2.0 million in Q1 2024.
  • Average Short-term Investments over 5 years is $65.7 million, with a median of $15.3 million recorded in 2020.
  • Peak YoY movement for Short-term Investments: crashed 95.22% in 2020, then surged 1675.3% in 2021.
  • A 5-year view of Short-term Investments shows it stood at $15.3 million in 2020, then soared by 1675.3% to $270.8 million in 2021, then crashed by 90.64% to $25.3 million in 2022, then plummeted by 40.87% to $15.0 million in 2023, then plummeted by 86.42% to $2.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $2.0 million in Q1 2024, $15.0 million in Q1 2023, and $25.3 million in Q1 2022.